DE60236579D1 - Bakteriophagenvermittelte impfung - Google Patents

Bakteriophagenvermittelte impfung

Info

Publication number
DE60236579D1
DE60236579D1 DE60236579T DE60236579T DE60236579D1 DE 60236579 D1 DE60236579 D1 DE 60236579D1 DE 60236579 T DE60236579 T DE 60236579T DE 60236579 T DE60236579 T DE 60236579T DE 60236579 D1 DE60236579 D1 DE 60236579D1
Authority
DE
Germany
Prior art keywords
bacteriophage
mediated vaccination
vaccination
mediated
vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60236579T
Other languages
English (en)
Inventor
John Bernard March
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BigDNA Ltd
Original Assignee
BigDNA Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BigDNA Ltd filed Critical BigDNA Ltd
Application granted granted Critical
Publication of DE60236579D1 publication Critical patent/DE60236579D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE60236579T 2001-03-23 2002-03-25 Bakteriophagenvermittelte impfung Expired - Lifetime DE60236579D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0107319.6A GB0107319D0 (en) 2001-03-23 2001-03-23 Bacteriophage-mediated immunisation
PCT/GB2002/001413 WO2002076498A2 (en) 2001-03-23 2002-03-25 Bacteriophage-mediated immunisation

Publications (1)

Publication Number Publication Date
DE60236579D1 true DE60236579D1 (de) 2010-07-15

Family

ID=9911416

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60236579T Expired - Lifetime DE60236579D1 (de) 2001-03-23 2002-03-25 Bakteriophagenvermittelte impfung

Country Status (13)

Country Link
US (1) US7128916B2 (de)
EP (1) EP1370284B1 (de)
JP (1) JP4653934B2 (de)
AT (1) ATE469655T1 (de)
AU (1) AU2002251192B2 (de)
CA (1) CA2441601C (de)
CY (1) CY1111286T1 (de)
DE (1) DE60236579D1 (de)
DK (1) DK1370284T3 (de)
ES (1) ES2345434T3 (de)
GB (1) GB0107319D0 (de)
PT (1) PT1370284E (de)
WO (1) WO2002076498A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0222824D0 (en) * 2002-10-02 2002-11-06 Moredun Res Inst Bacteriophage-mediated immunisation II
WO2006095345A2 (en) * 2005-03-08 2006-09-14 Ramot At Tel-Aviv University Ltd. Targeted drug-carrying bacteriophages
CA2673593A1 (en) * 2005-12-23 2007-07-05 Hygea Biopharma, Inc. Immunologically enhanced recombinant vaccines
JP2007204415A (ja) * 2006-02-01 2007-08-16 Tokyo Institute Of Technology ファージ頭殻提示腸管免疫誘導型ワクチン
GB0808780D0 (en) * 2008-05-15 2008-06-18 Big Dna Ltd Fish vaccines
WO2011045573A2 (en) 2009-10-15 2011-04-21 University Court Of The University Of Edinburgh Staphylococcal antigens
WO2011080505A2 (en) 2009-12-28 2011-07-07 Bigdna Ltd Method of growing phage for commercial use
GB201112587D0 (en) 2011-07-22 2011-09-07 Moredun Res Inst Vaccine
CA2907234A1 (en) 2013-03-15 2014-09-25 Altria Client Services Llc Bacteriophage and methods of making and using
WO2016123427A1 (en) 2015-01-29 2016-08-04 Altria Client Services Llc Bacteriophage and methods of using
US10357056B2 (en) 2015-01-29 2019-07-23 Altria Client Services Llc Endolysin from bacteriophage against Geobacillus and methods of using
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
GB201600075D0 (en) * 2016-01-03 2016-02-17 Glaxosmithkline Biolog Sa Immunogenci composition
WO2021202361A1 (en) * 2020-03-30 2021-10-07 North Carolina State University Engineered bacteria for use in vaccine compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736388A (en) 1994-12-30 1998-04-07 Chada; Sunil Bacteriophage-mediated gene transfer systems capable of transfecting eukaryotic cells
AU3737297A (en) * 1996-08-05 1998-02-25 Brigham And Women's Hospital Bacteriophage-mediated gene therapy
US6054312A (en) * 1997-08-29 2000-04-25 Selective Genetics, Inc. Receptor-mediated gene delivery using bacteriophage vectors
AU746040B2 (en) 1998-04-24 2002-04-11 Regents Of The University Of California, The Targeted gene delivery to cells by filamentous bacteriophage
CA2381755A1 (en) * 1999-08-26 2001-03-01 Vion Pharmaceuticals, Inc. Compositions and methods for delivery of an agent using attenuated salmonella containing phage

Also Published As

Publication number Publication date
WO2002076498A3 (en) 2003-08-14
DK1370284T3 (da) 2010-09-27
CY1111286T1 (el) 2015-08-05
AU2002251192B2 (en) 2006-11-16
WO2002076498A2 (en) 2002-10-03
EP1370284A2 (de) 2003-12-17
ATE469655T1 (de) 2010-06-15
GB0107319D0 (en) 2001-05-16
CA2441601A1 (en) 2002-10-03
JP4653934B2 (ja) 2011-03-16
EP1370284B1 (de) 2010-06-02
ES2345434T3 (es) 2010-09-23
JP2004525931A (ja) 2004-08-26
CA2441601C (en) 2012-03-13
US20040121974A1 (en) 2004-06-24
US7128916B2 (en) 2006-10-31
PT1370284E (pt) 2010-08-03

Similar Documents

Publication Publication Date Title
CY1111286T1 (el) Ανοσοποιηση διαμεσολαβουμενη απο βακτηριοφαγα
EA202192570A1 (ru) Иммуногенные композиции и вакцины, содержащие пептиды и белки вируса африканской чумы свиней, и их применение
DE60232577D1 (de) Oligomerische komplexe von chimären proteinen mit verbessertem immunogenen potential
MXPA05009580A (es) Vacuna contra el virus de la influenza.
ATE475675T1 (de) Verwendung prokariotischer pest-ähnlicher peptide zur verstärkung der immunogenität von antigenen
ATE383375T1 (de) Wti-modifiziertes peptid
DE60132893D1 (de) Antigene polypeptide
EA200700849A1 (ru) Первичная/бустерная противомалярийная вакцина
HUP9902438A2 (hu) Parapoxvírus vektorok
ZA202300548B (en) Self-amplifying sars-cov-2 rna vaccine
GB0608368D0 (en) Process for making Oligopeptides
CY1106433T1 (el) Εμβολια κοκκιδιωσης
MY144766A (en) Plant virus coat fusion proteins with gdf8 epitopes and vaccines thereof
DK1368372T3 (da) Peptid med affinitet til det virale gp120-protein samt anvendelse deraf
DK1545594T3 (da) Bakteriofag-medieret immunisering mod Hepatitis
NZ515041A (en) Nucleic acid immunization
DK1499349T3 (da) Rekombinante hybrid-allergenkonstrukter med reduceret allergenitet, der bibeholder det naterulige allergens immunogenitet
GB0409559D0 (en) Polypeptide
WO2004056316A8 (en) Vaccines against hiv-1 tat protein to generate neutralizing antibodies
ATE525470T1 (de) Antigene epitope des faktors viii, inhibitoren dagegen, und deren verwendungen
ATE355077T1 (de) Verwendung von peptidvektoren zur verbesserung der immunantwort gegen antigene
ITTO20010795A0 (it) Polipeptide isolato basato sulla sequenza della proteina p17 utile come vaccino anti-hiv.
CO5370685A1 (es) Imunogeno compuesto por un peptido y unna proteina d de haemophilus influenzae que actua como portadora
TH86213B (th) การทำให้วัคซีนซึ่งเพิ่มการเจริญเติบโตที่มีอีพิโทปเป็นส่วนประกอบหลักเป็นกลาง
RU2008149816A (ru) Рекомбинантный иммуноген для иммунизации против белка р17 вируса иммунодефицита человека